Characterizing mice lacking Inositol Polyphosphate-4-Phosphatase Type II B (INPP4B), Zhang et al. discovered that SREBP1 signaling is activated in livers of Inpp4b−/− males leading to development of NAFLD and insulin resistance. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.